Analysis

Intel’s stunning 186% year-to-date surge has hit a wall, with the stock shedding nearly 12% in a single week to...

Novo Nordisk closed the week at €43.32, adding 1.29% on Friday alone, as a wave of analyst upgrades and a...

Companies that try to silence workers about their salaries are finding such bans unenforceable. Salary is not a trade secret,...

The Wall Street consensus on IREN is remarkably bullish, yet the stock sits nearly 46% below its November 2025 high...

Oracle has chosen an unusual proving ground for its cloud ambitions: the pit lane. On July 9, 2026, the software...

Take-Two Interactive is breaking its own routine. The publisher will release its fiscal first-quarter results before the opening bell on...

A single drug that could treat inherited blindness regardless of which gene is broken — that is the audacious promise...

The bull case for Microsoft has rarely looked more compelling—or more contested. Analysts see a near-$600 price target in the...

BayWa’s two largest shareholders, holding a combined 67% stake, are handing their shares to a trustee for an interim period,...

A debt-free balance sheet, $222.8 million in cash and a 121 percent revenue surge would normally be the stuff of...